معرفی
Frederick Wilson, MD, PhD, is an Assistant Professor of Medical Oncology and Hematology at Yale School of Medicine, with a secondary appointment in Genetics. He specializes in lung cancer treatment and research, focusing on cancer genomics, genetic vulnerabilities, and targeted therapies. His work includes identifying RASGRF1 fusions as oncogenic drivers and developing therapeutic strategies against MTAP-deleted cancers. Wilson is affiliated with the Yale Cancer Center and multidisciplinary teams like the Center for Thoracic Cancers. He completed his MD (Harvard, 2007) and PhD (Yale, 2002), with postdoctoral training at the Broad Institute and Dana-Farber. His clinical trials include AG-270/S095033 for MTAP-deleted cancers and NC318 for NSCLC immunotherapy. He advises on precision medicine tumor boards and collaborates with researchers like Roy Herbst and Heather Gerrish.
